Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes

OBJECTIVE: Thiazolidinediones reduce hepatic steatosis and increase HDL cholesterol levels. In mice with human-like lipoprotein metabolism (APOE*3-Leiden.CETP transgenic mice), a decrease in hepatic triglyceride content is associated with a decrease in plasma cholesteryl ester transfer protein (CETP...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Jonker, Jacqueline T., Wang, Yanan, de Haan, Willeke, Diamant, Michaela, Rijzewijk, Luuk J., van der Meer, Rutger W., Lamb, Hildo J., Tamsma, Jouke T., de Roos, Albert, Romijn, Johannes A., Rensen, Patrick C.N., Smit, Johannes W.A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Diabetes Association 2010
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2890371/
https://ncbi.nlm.nih.gov/pubmed/20150294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc09-1935
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak